Ekso Bionics earns Medicare win for exoskeleton tech

The Indego Personal exoskeleton. [Image from Ekso Bionics]Ekso Bionics (Nasdaq:EKSO) announced that the Centers for Medicare & Medicaid Services (CMS) proposed a payment level for its exoskeleton.

The Pricing, Data Analysis, and Coding (PDAC) contractor completed its review of the Ekso Indego Personal, approving the use of Healthcare Common Procedure Coding System (HCPCS) Code K1007 to bill Medicare for the device. CMS proposed a payment level of $94,617 for devices under this code. Ekso expects CMS to announce the pricing in February 2024 before the anticipated effective date of April 1, 2024.

Ekso Indego Personal is a modular, lightweight and portable exoskeleton that people can use in most home and community environments. The device features an advanced gait mode for users to reach faster walking speeds, reaching new levels of independence.

This marks the latest reimbursement win for exoskeleton technology. Starting on Jan. 1, 2024, CMS will cover ex…

Read more
  • 0

FDA clears Ekso Bionics’ robotic exoskeleton for use with MS patients

[Image from Ekso Bionics]Ekso Bionics (Nasdaq:EKSO) announced today that it received FDA 510(k) clearance for its EksoNR robotic exoskeleton.

Richmond, California-based Ekso Bionics designed the EksoNR technology for use with Multiple Sclerosis (MS) patients.

According to a news release, EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use in patients with MS, significantly expanding the device’s use to a broader group of patients.

The latest generation of the Ekso Bionics platform, the EksoNR previously received clearance for stroke and spinal cord rehabilitation in 2016, then acquired brain injury (ABI) in 2020. Ekso said it was the first of its kind to receive a stroke indication and stands as the only exoskeleton with indications for ABI and now MS. EksoNR also has CE mark, the company said.

“As a leader in early-to-market wearable robotic solutions for medical rehabilitation, we are committed to maximizing…

Read more
  • 0